Hepatitis B Virus

Hepatitis B Virus is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or .

The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

-- The first section of this topic is shown below --

General Principles

  • The US is considered an area of low prevalence for the infection. Eight genotypes of HBV have been identified (A through H). The prevalence of HBV genotypes varies depending on the geographic location. Genotypes A, B, and C are the most prevalent in the US.
  • Modes of transmission include vertical (mother to infant) and horizontal (person to person) via the following routes: parenteral or percutaneous (e.g., injection drug use, needlestick injuries), direct contact with the blood or open sores of an infected person, and sexual contact with an infected individual.
  • The rate of progression from acute to chronic HBV is approximately 90% for a perinatal-acquired infection, 20%–50% for infections acquired between the age of 1 and 5 years, and <5% for an adult-acquired infection.

-- To view the remaining sections of this topic, please or --

General Principles

  • The US is considered an area of low prevalence for the infection. Eight genotypes of HBV have been identified (A through H). The prevalence of HBV genotypes varies depending on the geographic location. Genotypes A, B, and C are the most prevalent in the US.
  • Modes of transmission include vertical (mother to infant) and horizontal (person to person) via the following routes: parenteral or percutaneous (e.g., injection drug use, needlestick injuries), direct contact with the blood or open sores of an infected person, and sexual contact with an infected individual.
  • The rate of progression from acute to chronic HBV is approximately 90% for a perinatal-acquired infection, 20%–50% for infections acquired between the age of 1 and 5 years, and <5% for an adult-acquired infection.

There's more to see -- the rest of this topic is available only to subscribers.